Management Unterbauchraumforderungen in der Schwangerschaft – Fallbeschreibung eines extraovariell-intraabdominalen Dysgerminoms mit Überblick über die Literatur
暂无分享,去创建一个
[1] C. V. Gonçalves,et al. Treatment of bilateral ovarian dysgerminoma with 11-year follow-up: A case report , 2018, Annals of medicine and surgery.
[2] C. Rodríguez-Galindo,et al. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? , 2018, Gynecologic oncology.
[3] Yingmei Wang,et al. Ovarian dysgerminoma in pregnancy: A case report and literature review , 2018, Cancer biology & therapy.
[4] A. Bharatha,et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. , 2016, JAMA.
[5] Xiaohua Wu,et al. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery , 2016, Current Treatment Options in Oncology.
[6] F. Amant,et al. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. , 2015, American journal of obstetrics and gynecology.
[7] J. Greenspan,et al. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. , 2015, American journal of obstetrics and gynecology.
[8] Michiko Kodama,et al. Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature. , 2014, European journal of obstetrics, gynecology, and reproductive biology.
[9] A. Shaaban,et al. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.
[10] S. Soundararaghavan,et al. Mediastinal dysgerminoma complicating pregnancy , 2012, Obstetric medicine.
[11] F. Amant,et al. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review , 2012, BMC Medicine.
[12] T. Al-Tweigeri,et al. Pure dysgerminoma of the ovary: a single institutional experience of 65 patients , 2012, Medical Oncology.
[13] A. Orçun,et al. Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study , 2012, Archives of Gynecology and Obstetrics.
[14] Kyung-Ja Cho,et al. Primary retroperitoneal dysgerminoma presenting as an adrenal tumor: A case report and literature review , 2011, Pathology international.
[15] F. Amant,et al. Gynaecologic cancer complicating pregnancy: an overview. , 2010, Best practice & research. Clinical obstetrics & gynaecology.
[16] E. Cardonick,et al. Perinatal Outcomes of a Pregnancy Complicated by Cancer, Including Neonatal Follow-Up After in Utero Exposure to Chemotherapy: Results of an International Registry , 2009, American journal of clinical oncology.
[17] M. Cote,et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. , 2008, Gynecologic oncology.
[18] Liang Cheng,et al. OCT4: A Novel Biomarker for Dysgerminoma of the Ovary , 2004, The American journal of surgical pathology.
[19] S. Hsueh,et al. Treatment of malignant germ cell tumors of the ovary. , 1994, Journal of the Formosan Medical Association = Taiwan yi zhi.
[20] W. S. Kammerer,et al. Nonobstetric surgery during pregnancy. , 1979, The Medical clinics of North America.
[21] Committee Opinion No. 696: Nonobstetric Surgery During Pregnancy. , 2017, Obstetrics and gynecology.
[22] F. Amant,et al. Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development. , 2011, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.
[23] S. Schmidt,et al. Geburtshilfe und Perinatalmedizin , 2010 .
[24] K. Van Calsteren. Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development , 2010, Facts, views & vision in ObGyn.